Baeuerle Patrick 4
4 · Harpoon Therapeutics, Inc. · Filed Jun 5, 2019
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2019-06-03+10,167→ 10,167 totalExercise: $11.84Exp: 2029-06-02→ Common Stock (10,167 underlying)
Footnotes (1)
- [F1]The stock option will fully vest and become exercisable on June 3, 2020, subject to the continuous service of the Reporting Person with the Issuer on such date.